Stemline Therapeutics Inc (NASDAQ:STML)

17.10
Delayed Data
As of Jun 21
 -0.60 / -3.39%
Today’s Change
7.30
Today|||52-Week Range
20.55
+9.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues299.4K299.4K0.000.00
 
 
 
Depreciation And Amortization953.00952.0011.8K11.8K
 
 
 
 
 
 
Operating ExpensesGross Income-----11.8K-11.8K
 
 
 
General Expenses16.0M16.6M21.9M18.6M
 
 
 
 
 
Research And Development11.5M12.4M16.7M12.7M
 
 
 
 
 
Total Operating Expenses16.0M16.6M21.9M18.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.7M-16.3M-21.9M-18.6M
 
 
 
 
 
Other Expenses0.00-3.2K-3.1K-3.9K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.5M-16.1M-21.7M-18.4M
 
 
 
 
 
Net Income-15.5M-16.1M-21.7M-18.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.4M23.5M23.5M26.8M
 
 
 
 
 
Shares To Calculate EPS Diluted23.4M23.5M23.5M26.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.66-$0.68-$0.93-$0.69
 
 
 
 
 
EPS Diluted-$0.66-$0.68-$0.92-$0.69